Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 29 Neoplasms 5 Glioma 4 Ovarian Neoplasms 3 Neoplasm Metastasis 3 Melanoma 3 Glioblastoma 3 Rhabdoid Tumor 2 Neoplasms, Germ Cell and Embryonal 2 Medulloblastoma 2 Lymphoma 2 Liposarcoma 2 Fallopian Tube Neoplasms 2 Diffuse Intrinsic Pontine Glioma 2 Brain Neoplasms 2 Astrocytoma 2 Thymus Neoplasms 1 Teratoma 1 Solid Tumors Harboring a BRAF V600 Mutation 1 Sarcoma, Synovial 1 Sarcoma 1 Recurrence 1 Pyloric Stenosis, Hypertrophic 1 Prostatic Neoplasms 1 Pinealoma 1 Osteitis Deformans 1 Oligodendroglioma 1 Non functioning pancreatic endocrine tumor 1 Neurofibrosarcoma 1 Neuroendocrine Tumors 1

Interventions

ribociclib 1 palbociclib 1 abemaciclib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × DILI × ribociclib × Clear all

NCT06367335 2024-04-16

ETIC

University of Milano Bicocca

DILI

Data powered by HemOnc (CC BY 4.0) Colophon ⚡